Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2014; 6(6): 370-383
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Management of cytomegalovirus infection and disease in liver transplant recipients
Jackrapong Bruminhent, Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, United States
Raymund R Razonable, Division of Infectious Diseases and the William J von Liebig Center for Transplantation and Clinical Regeneration, College of Medicine, Mayo Clinic, Rochester, MN 55905, United States
Author contributions: Bruminhent J and Razonable RR contributed equally to this review paper.
Correspondence to: Raymund R Razonable, MD, Division of Infectious Diseases and the William J von Liebig Center for Transplantation and Clinical Regeneration, College of Medicine, Mayo Clinic, Marian Hall 5th Floor, 200 First Street SW, Rochester, MN 55905, United States. razonable.raymund@mayo.edu
Telephone: +1-507-2843747 Fax: +1-507-2557767
Received: November 12, 2013
Revised: January 23, 2014
Accepted: March 13, 2014
Published online: June 27, 2014
Revised: January 23, 2014
Accepted: March 13, 2014
Published online: June 27, 2014
Core Tip
Core tip: This paper summarizes the current state in the management of cytomegalovirus disease after liver transplantation, including a review of recently updated guidelines for diagnosis, prevention and treatment.